Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company announced that its stock closed yesterday’s up 0.36 (14.52%) to 2.84 on 2,969,972 volume shares traded. The company hit a 52-week high of $4.78 so far today. Somaxon Pharmaceuticals, stocks continue to showed better performance on market trade.

The company focuses on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology. Somaxon Pharmaceuticals, Inc. was founded in 2003 and is headquartered in San Diego, California.

Last Trade: 2.84
Trade Time: Nov 25
Change: Up 0.36 (14.52%)
Prev Close: 2.48
Open: 2.57
Day’s Range: 2.51 – 2.94
52wk Range: 0.18 – 4.78
Volume: 2,969,972
Avg Vol (3m): 454,655
Market Cap: 67.13M

About Somaxon Pharmaceuticals, Inc.

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology. The company has completed four Phase III clinical trials for its lead product candidate, Silenor (doxepin hydrochloride) for the treatment of insomnia.